Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Maria Lapteva, Marwa A. Sallam, Alexandre Goyon, Davy Guillarme, Jean-Luc Veuthey & Yogeshvar N. Kalia. (2020) Non-invasive targeted iontophoretic delivery of cetuximab to skin. Expert Opinion on Drug Delivery 17:4, pages 589-602.
Read now
Read now
Selcuk Seber, Aylin Gonultas, Ozlem Ozturk & Tarkan Yetisyigit. (2016) Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy. OncoTargets and Therapy 9, pages 945-948.
Read now
Read now
Uwe Wollina. (2014) Update of cetuximab for non-melanoma skin cancer. Expert Opinion on Biological Therapy 14:2, pages 271-276.
Read now
Read now
Articles from other publishers (27)
Mahsa Khayyati Kohnehshahri, Aila Sarkesh, Leila Mohamed Khosroshahi, Zanyar HajiEsmailPoor, Ali Aghebati-Maleki, Mehdi Yousefi & Leili Aghebati-Maleki. (2023) Current status of skin cancers with a focus on immunology and immunotherapy. Cancer Cell International 23:1.
Crossref
Crossref
Joanna Pastwińska, Kaja Karaś, Iwona Karwaciak & Marcin Ratajewski. (2022) Targeting EGFR in melanoma – The sea of possibilities to overcome drug resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:4, pages 188754.
Crossref
Crossref
Kylee J. B. Kus & Emily S. Ruiz. (2021) Non-Surgical Treatments for Keratinocyte Carcinomas. Advances in Therapy 38:12, pages 5635-5648.
Crossref
Crossref
Enrico Zelin, Iris Zalaudek, Marina Agozzino, Caterina Dianzani, Arianna Dri, Nicola Di Meo, Roberta Giuffrida, Giovanni Francesco Marangi, Nicoleta Neagu, Paolo Persichetti, Ludovica Toffoli & Claudio Conforti. (2021) Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma. Current Treatment Options in Oncology 22:4.
Crossref
Crossref
Paola Queirolo, Andrea Boutros & Enrica Teresa Tanda. 2021. Practical Medical Oncology Textbook. Practical Medical Oncology Textbook
979
1007
.
Fateme Rajabi. 2020. Cancer Immunology. Cancer Immunology
291
304
.
Erik T Petersen, Saqib R Ahmed, Leon Chen, Sirunya Silapunt & Michael R Migden. (2019) Review of systemic agents in the treatment of advanced cutaneous squamous cell carcinoma. Future Oncology 15:27, pages 3171-3184.
Crossref
Crossref
Zhan-Yan Pan, Jia Chen, Qiong Wu, Ting-Ting Hu, Lingyi Lu & Qiang Ju. (2018) Activation and overexpression of the aryl hydrocarbon receptor contribute to cutaneous squamous cell carcinomas: an immunohistochemical study. Diagnostic Pathology 13:1.
Crossref
Crossref
Carlo Capalbo, Francesca Belardinilli, Marco Filetti, Claudia Parisi, Marialaura Petroni, Valeria Colicchia, Alessandra Tessitore, Matteo Santoni, Anna Coppa, Giuseppe Giannini & Paolo Marchetti. (2018) Effective treatment of a platinum‑resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition. Molecular and Clinical Oncology.
Crossref
Crossref
Rafał Kampa, Ilona Bednarek & Daniel Sypniewski. (2018) Monoclonal antibodies in regulation of signal transduction
of Epidermal Growth Factor Receptor (EGFR) pathway in cancer cells. Annales Academiae Medicae Silesiensis 72, pages 12-20.
Crossref
Crossref
Tobin J. StromJimmy J. CaudellLouis B. Harrison. (2016) Management of BCC and SCC of the Head and Neck. Cancer Control 23:3, pages 220-227.
Crossref
Crossref
Michael Sand, Falk G Bechara, Daniel Sand, Thilo Gambichler, Stephan A Hahn, Michael Bromba, Eggert Stockfleth & Schapoor Hessam. (2016) Expression profiles of long noncoding RNAs in cutaneous squamous cell carcinoma. Epigenomics 8:4, pages 501-518.
Crossref
Crossref
Prasanth Ganesan, Siraj M. Ali, Kai Wang, George R. Blumenschein, Bita Esmaeli, Robert A. Wolff, Vincent A. Miller, Phillip J. Stephens, Jeffery S. Ross, Gary A. Palmer & Filip Janku. (2016) Epidermal Growth Factor Receptor P753S Mutation in Cutaneous Squamous Cell Carcinoma Responsive to Cetuximab-Based Therapy. Journal of Clinical Oncology 34:5, pages e34-e37.
Crossref
Crossref
Rafael Salido Vallejo, Gloria Garnacho Saucedo, Carmen María Alcántara Reifs & Antonio Vélez García-Nieto. (2015) Abordaje terapéutico del carcinoma escamoso cutáneo no operable. Piel 30:9, pages 594-608.
Crossref
Crossref
Tobin Strom & Louis B. Harrison. (2015) Radiotherapy for management of basal and squamous cell carcinoma. Current Problems in Cancer 39:4, pages 237-247.
Crossref
Crossref
Curtis R. Pickering, Jane H. Zhou, J. Jack Lee, Jennifer A. Drummond, S. Andrew Peng, Rami E. Saade, Kenneth Y. Tsai, Jonathan L. Curry, Michael T. Tetzlaff, Stephen Y. Lai, Jun Yu, Donna M. Muzny, Harshavardhan Doddapaneni, Eve Shinbrot, Kyle R. Covington, Jianhua Zhang, Sahil Seth, Carlos Caulin, Gary L. Clayman, Adel K. El-Naggar, Richard A. Gibbs, Randal S. Weber, Jeffrey N. Myers, David A. Wheeler & Mitchell J. Frederick. (2014) Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma. Clinical Cancer Research 20:24, pages 6582-6592.
Crossref
Crossref
Sara Falivene, Francesca Maria Giugliano, Antonio Maria Grimaldi, Rossella Di Franco, Diego Toledo, Matteo Muto, Fabrizio Cammarota, Valentina Borzillo, Paolo Antonio Ascierto & Paolo Muto. (2014) Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report. BMC Dermatology 14:1.
Crossref
Crossref
Jonathan M. Tomaszewski, Haim Gavriel, Emma Link, Sholeh Boodhun, Andrew Sizeland & June Corry. (2014) Aggressive behavior of Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. The Laryngoscope 124:9, pages 2043-2048.
Crossref
Crossref
Ben Gurney & Carrie Newlands. (2014) Management of regional metastatic disease in head and neck cutaneous malignancy.1. Cutaneous squamous cell carcinoma. British Journal of Oral and Maxillofacial Surgery 52:4, pages 294-300.
Crossref
Crossref
Umut Varol, Ibrahim Yildiz, Ahmet Alacacioglu & Ruchan Uslu. (2014) Anticancer Therapy for Breast Cancer Patients with Skin Metastases Refractory to Conventional Treatments. Asian Pacific Journal of Cancer Prevention 15:4, pages 1885-1887.
Crossref
Crossref
Daniel C Gaffney, H Peter Soyer & Fiona Simpson. (2014) The epidermal growth factor receptor in squamous cell carcinoma: An emerging drug target. Australasian Journal of Dermatology 55:1, pages 24-34.
Crossref
Crossref
Katrin L. Conen, Natalie Fischer, Günther F.L. Hofbauer, Bahar Shafaeddin-Schreve, Ralph Winterhalder, Christoph Rochlitz & Alfred Zippelius. (2014) Cetuximab in Metastatic Squamous Cell Cancer of the Skin: A Swiss Case Series. Dermatology 229:2, pages 97-101.
Crossref
Crossref
Katherine Boyd, Sofia M Shea & James Patterson. (2013) Cetuximab for treatment of advanced squamous cell carcinoma in solid organ transplant recipientsCetuximab als Therapie fortgeschrittener Plattenepithelkarzinome bei Organtransplantierten. Wiener Medizinische Wochenschrift 163:15-16, pages 372-375.
Crossref
Crossref
Uwe Wollina & Georgi Tchernev. (2013) Advanced basal cell carcinomaDas fortgeschrittene Basalzellkarzinom. Wiener Medizinische Wochenschrift 163:15-16, pages 347-353.
Crossref
Crossref
Jan B VermorkenPol Specenier. 2013. Monoclonal Antibodies Targeting EGFR/HER2 and Clinical Outcomes in Cancer Treatment. Monoclonal Antibodies Targeting EGFR/HER2 and Clinical Outcomes in Cancer Treatment
72
89
.
M. Alter, I. Satzger, A. Mattern, A. Kapp & R. Gutzmer. (2013) Treatment of Advanced Cutaneous Squamous Cell Carcinomas with Epidermal Growth Factor Receptor Inhibitors. Dermatology 227:4, pages 289-294.
Crossref
Crossref
Metin Yilmaz, Görkem Eskiizmir & Oren Friedman. (2012) Cutaneous Squamous Cell Carcinoma of the Head and Neck. Facial Plastic Surgery Clinics of North America 20:4, pages 473-481.
Crossref
Crossref